Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
.jpg)
.avif)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.png)
HBS
In Vitro Assays
Cell Culture & Characterization
Toxicology
Ignyte Bio
Blog
What AI Finds in Clinical Notes About Myasthenia Gravis That Claims Data Misses
October 15, 2026
Sponsored by:
Sponsor
Read blog
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Norstella
Blog
In Vivo Study: From Study Design, Execution to Pathology Assessment in One Laboratory at APS
October 8, 2026
Sponsored by:
Sponsor
Read blog
Pharmacology
Disease Models
DMPK
Biomarkers
Toxicology
Applied Pathology Systems
Blog
What to Know About AAV Quality Before the Experiment Begins
September 22, 2026
Sponsored by:
Sponsor
Read blog
DNA & RNA
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Protein Sciences
Vector Biolabs
Blog
Immortalized vs. Primary Cells: Choosing the Right Model for Your Research
September 15, 2026
Sponsored by:
Sponsor
Read blog
Cell Culture & Characterization
In Vitro Assays
HBS
NHBS
Disease Models
Innoprot
Blog
Connecting Discovery: How Integrated Infrastructure Supports Better Decisions
September 9, 2026
Sponsored by:
Sponsor
Read blog
Antibodies
Protein Sciences
In Vitro Assays
Cell Culture & Characterization
Jubilant Biosys
.png)
Blog
The Evolving Landscape of Drug Discovery for Metabolic Diseases
July 14, 2026
Sponsored by:
Sponsor
Read blog
Pharmacology
In Vitro Assays
Cell Culture & Characterization
BPS Bioscience Inc.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Real-World Data (RWD)
Market Access
No items found.
Blog
Accelerating the Design–Build–Test–Learn Cycle for AI-Driven Antibody Discovery
June 25, 2026
Sponsored by:
Sponsor
Read blog
Antibodies
Protein Sciences
In Vitro Assays
Cell Culture & Characterization
Biointron
Blog
Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery
June 16, 2026
Sponsored by:
Sponsor
Read blog
Discovery Chemistry
Pharmacology
Protein Sciences
SandboxAQ
Blog
Reducing risk in CRO studies: Choosing the right cell models for outsourced research
June 11, 2026
Sponsored by:
Sponsor
Read blog
Cell Culture & Characterization
In Vitro Assays
HBS
Toxicology
Pharmacology
PromoCell
.avif)
In Vitro Assays
DMPK
Toxicology
Lauren Brown
Alec Salminen
LifeNet Health LifeSciences
Scientist.com
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Mac Bonafede
Janna Manjelievskaia
Veradigm
No items found.
Disease Models
Biomarkers
Cell Culture & Characterization
In Vitro Assays
Pharmacology
Koji Murakami
Tomonori Kitaura
Axcelead Drug Discovery Partners, Inc.
No items found.
Bioimaging
Cell Culture & Characterization
Discovery Chemistry
In Vitro Assays
Instrumentation & Products
Brice Murciano
Céline Ronin
Marc Vitorino
Novalix
No items found.
Bioimaging
Discovery Chemistry
Disease Models
In Vitro Assays
Protein Sciences
Babatunde Ekundayo
KACTUS
No items found.
Pharmacology
Cell Culture & Characterization
Marta Costa
STEMCELL Technologies Inc.
No items found.
Disease Models
Toxicology
Pharmacology
DMPK
In Vitro Assays
Courtney Noah
René Overmeer
Paul Walker
BioIVT
HUB Organoids
Evotec
Scientist.com
HBS
Real-World Data (RWD)
Pharmacology
Clinical Trials
Nicolas Weinbreck
Caroline Rancati
Pauline Mespoulhé
France Tissue Bank
No items found.
Disease Models
Pharmacology
Kosuke Hitaka
Shuichi Takagahara
Axcelead Drug Discovery Partners, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Disease Models
Simote T. Foliaki
Harvard Bioscience, Inc.
No items found.
Disease Models
Instrumentation & Products
Karyn Esser
Aurora Scientific, Inc.
American Physiological Society
Pharmacology
Disease Models
Catherine Robin-Jagerschmidt
Didier Merciris
Vincent Dumont
Novalix
Scientist.com
Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
.avif)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.
Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM
Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences